Quick Answer
Nu-Med Plus, Inc. reported Total Revenue of $0.00 for fiscal year 2020.
Nu-Med Plus, Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | $0.00 | $0.00 |
| Net Income | -$68.3K +45.6% |
-$125.5K +3.6% |
-$130.2K +84.3% |
-$830.1K +58.7% |
-$2.01M -93.8% |
-$1.04M +12.8% |
| Diluted EPS | $0.00 | $0.00 | $0.00 +100.0% |
-$0.01 | — | — |
| Total Assets | $9.4K -30.3% |
$13.5K -83.1% |
$79.5K +258.9% |
$22.2K -96.0% |
$557.1K +1117.0% |
$45.8K -89.2% |
| Cash and Equivalents | $2.4K -65.1% |
$6.8K | — | — | $188.5K +2562.9% |
$7.1K -95.8% |
| Stockholders Equity | -$215.1K -46.6% |
-$146.8K -132.8% |
-$63.0K +52.4% |
-$132.4K -128.3% |
$467.7K +226.3% |
-$370.4K -863.4% |
| Operating Income | -$63.3K +47.5% |
-$120.5K +33.8% |
-$182.2K +78.3% |
-$839.4K +57.9% |
-$1.99M -95.7% |
-$1.02M +12.8% |
| Shares Outstanding | 83.55M +0.0% |
83.55M +2.7% |
81.35M +2.5% |
79.35M +55.5% |
51.03M +14.7% |
44.48M +7.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2021 | $0.00 | — | — |
| Net Income | September 30, 2025 | -$12.0K | +35.9% | -2.6% |
| Diluted EPS | September 30, 2025 | $0.00 | — | — |
| Total Assets | September 30, 2025 | $5.0K | -26.2% | -38.2% |
| Cash and Equivalents | September 30, 2021 | $31.8K | +1.1% | -56.3% |
| Stockholders Equity | September 30, 2025 | -$258.7K | -26.5% | -4.9% |
| Operating Income | September 30, 2025 | -$10.1K | +42.2% | +3.3% |
| Shares Outstanding | September 30, 2025 | 83.55M | +0.0% | +0.0% |
- Nu-Med Plus, Inc. reported Total Revenue of $0.00 for fiscal year 2020.
- Nu-Med Plus, Inc. reported Net Income of -$68.3 thousand for fiscal year 2024.
- Nu-Med Plus, Inc. showed an increase of +45.6% in Net Income compared to the prior fiscal year.
- Nu-Med Plus, Inc. reported Diluted EPS of $0.00 per share for fiscal year 2024.
- Nu-Med Plus, Inc. reported Total Assets of $9.4 thousand for fiscal year 2024.
- Nu-Med Plus, Inc. showed a decrease of -30.3% in Total Assets compared to the prior fiscal year.
- Nu-Med Plus, Inc. reported Cash and Equivalents of $2.4 thousand for fiscal year 2024.
- Nu-Med Plus, Inc. showed a decrease of -65.1% in Cash and Equivalents compared to the prior fiscal year.
- Nu-Med Plus, Inc. reported Stockholders Equity of -$215.1 thousand for fiscal year 2024.
- Nu-Med Plus, Inc. showed a decrease of -46.6% in Stockholders Equity compared to the prior fiscal year.
- Nu-Med Plus, Inc. reported Operating Income of -$63.3 thousand for fiscal year 2024.
- Nu-Med Plus, Inc. showed an increase of +47.5% in Operating Income compared to the prior fiscal year.
- Nu-Med Plus, Inc. reported Shares Outstanding of 83.55 million shares for fiscal year 2024.
- Nu-Med Plus, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: